Population-based incidence rates of breast cancers that yield negative testing results for estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 biomarkers (triple-negative breast cancer [TNBC] ) are 2-fold higher among African American women compared with white American women, and TNBC is a risk factor for breast cancer gene 1 (BRCA1) mutation carrier status that is independent of an individual's family history. These patterns, coupled with data revealing an increased frequency of TNBC among western, subSaharan Africans, suggest that African ancestry is associated with hereditary susceptibility for TNBC. Resources for collecting and analyzing germline DNA from blood and/or saliva specimens to evaluate for BRCA mutations are limited in low-and middle-income countries in Africa, and transporting specimens to laboratories in more affluent countries is challenging. Recent studies suggest that DNA extraction from formalinfixed, paraffin-embedded tumor specimens is feasible and accurate, 1,2 thereby providing a readily available resource for genetic studies. We report the results from a study motivated by the educational and research efforts of an international multidisciplinary breast cancer partnership. Selected BRCA mutations were analyzed among Ghanaian patients with breast cancer, exploring the effectiveness of collaborations between surgeons, oncologists, pathologists, and geneticists in assessing the genetics of breast cancer in low-and middleincome countries in Africa.
Methods | This study was approved by the Committee on Human Research Publication institutional review board for the Komfo Anokye Teaching Hospital and Kwame Nkrumah University of Science and Technology. The study population consisted of women with a family history of breast cancer who had received a diagnosis of locally advanced disease and were treated from September 2009 to August 2011 at Komfo Anokye Teaching Hospital in Kumasi, Ghana, with neoadjuvant chemotherapy followed by definitive breast/axillary surgery. Formalin-fixed paraffin-embedded samples were obtained from surgical resection specimens, and DNA was extracted from deparaffinized tissues and genotyped for 3 common BRCA mutations: BRCA1 185delAG, BRCA1 5382insC, and BRCA2 6174delT (Inqaba Biotechnical Industries Ltd). The process of obtaining patient consent and tissue studies was completed by Ghanaian medical staff.
Results | Of 521 patients, 94 (18.0%) met inclusion criteria and consented to participate ( 
